243 related articles for article (PubMed ID: 30005409)
21. An investigation of antitumor efficiency of novel sustained and targeted 5-fluorouracil nanoparticles.
Le VM; Wang JJ; Yuan M; Nguyen TL; Yin GF; Zheng YH; Shi WB; Lang MD; Xu LM; Liu JW
Eur J Med Chem; 2015 Mar; 92():882-9. PubMed ID: 25676729
[TBL] [Abstract][Full Text] [Related]
22. PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy.
Choi JY; Ramasamy T; Kim SY; Kim J; Ku SK; Youn YS; Kim JR; Jeong JH; Choi HG; Yong CS; Kim JO
Acta Biomater; 2016 Jul; 39():94-105. PubMed ID: 27163403
[TBL] [Abstract][Full Text] [Related]
23. Chain-Length- and Saturation-Tuned Mechanics of Fluid Nanovesicles Direct Tumor Delivery.
Dai Z; Yu M; Yi X; Wu Z; Tian F; Miao Y; Song W; He S; Ahmad E; Guo S; Zhu C; Zhang X; Li Y; Shi X; Wang R; Gan Y
ACS Nano; 2019 Jul; 13(7):7676-7689. PubMed ID: 31187973
[TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy.
Zhang B; Wang T; Yang S; Xiao Y; Song Y; Zhang N; Garg S
J Control Release; 2016 Sep; 238():10-21. PubMed ID: 27432750
[TBL] [Abstract][Full Text] [Related]
25. Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo.
Nguyen VD; Min HK; Kim CS; Han J; Park JO; Choi E
Colloids Surf B Biointerfaces; 2019 Jan; 173():539-548. PubMed ID: 30343218
[TBL] [Abstract][Full Text] [Related]
26. F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent.
Fan S; Cao YX; Li GY; Lei H; Attiogbe MKI; Yao JC; Yang XY; Liu YJ; Hei YY; Zhang H; Cao L; Zhang XY; Du SS; Zhang GM; Zhang SQ
Eur J Med Chem; 2020 Sep; 202():112528. PubMed ID: 32650182
[TBL] [Abstract][Full Text] [Related]
27. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system.
Bwatanglang IB; Mohammad F; Yusof NA; Abdullah J; Alitheen NB; Hussein MZ; Abu N; Mohammed NE; Nordin N; Zamberi NR; Yeap SK
J Colloid Interface Sci; 2016 Oct; 480():146-158. PubMed ID: 27428851
[TBL] [Abstract][Full Text] [Related]
28. Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin.
Galbiati A; Tabolacci C; Morozzo Della Rocca B; Mattioli P; Beninati S; Paradossi G; Desideri A
Bioconjug Chem; 2011 Jun; 22(6):1066-72. PubMed ID: 21545180
[TBL] [Abstract][Full Text] [Related]
29. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
[TBL] [Abstract][Full Text] [Related]
30. Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance.
Chen Y; Cheng Y; Zhao P; Zhang S; Li M; He C; Zhang X; Yang T; Yan R; Ye P; Ma X; Xiang G
Int J Pharm; 2018 May; 542(1-2):266-279. PubMed ID: 29551747
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
32. pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment.
Nunes SS; Miranda SEM; de Oliveira Silva J; Fernandes RS; de Alcântara Lemos J; de Aguiar Ferreira C; Townsend DM; Cassali GD; Oliveira MC; Branco de Barros AL
Biomed Pharmacother; 2021 Dec; 144():112317. PubMed ID: 34634556
[TBL] [Abstract][Full Text] [Related]
33. Empowering hydrophobic anticancer drugs by ultrashort peptides: General Co-assembly strategy for improved solubility, targeted efficacy, and clinical application.
Gao F; Guo J; Liu S; Zhang F; Zhang Y; Wang L
J Colloid Interface Sci; 2024 Aug; 667():119-127. PubMed ID: 38631250
[TBL] [Abstract][Full Text] [Related]
34. Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs.
Reddy JA; Dorton R; Bloomfield A; Nelson M; Vetzel M; Guan J; Leamon CP
Clin Cancer Res; 2014 Apr; 20(8):2104-14. PubMed ID: 24429878
[TBL] [Abstract][Full Text] [Related]
35. Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan.
Riviere K; Kieler-Ferguson HM; Jerger K; Szoka FC
J Control Release; 2011 Aug; 153(3):288-96. PubMed ID: 21600250
[TBL] [Abstract][Full Text] [Related]
36. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
37. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
[TBL] [Abstract][Full Text] [Related]
38. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
39. Novel curcumin-loaded human serum albumin nanoparticles surface functionalized with folate: characterization and in vitro/vivo evaluation.
Song Z; Lu Y; Zhang X; Wang H; Han J; Dong C
Drug Des Devel Ther; 2016; 10():2643-9. PubMed ID: 27574403
[TBL] [Abstract][Full Text] [Related]
40. Folic acid-conjugated chitosan oligosaccharide-magnetic halloysite nanotubes as a delivery system for camptothecin.
Dramou P; Fizir M; Taleb A; Itatahine A; Dahiru NS; Mehdi YA; Wei L; Zhang J; He H
Carbohydr Polym; 2018 Oct; 197():117-127. PubMed ID: 30007596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
